On November 23, 2020 BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, reported that the Company will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference (Press release, BeiGene, NOV 23, 2020, View Source [SID1234571587]). Presentations will be available for registered attendees via the Piper Sandler conference site from November 23 to December 3, 2020.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

An archived replay will be available for 90 days following the event in the investors section of BeiGene’s website at View Source or View Source